Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients-Reference-Cited by-同舟云学术

Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients

Published:2015-08 Issue:32 Volume:94 Page:e1321
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Hsiao Liang-Tsai,Chiou Tzeon-Jye,Gau Jyh-Pyng,Yang Ching-Fen,Yu Yuan-Bin,Liu Chun-Yu,Liu Jin-Hwang,Chen Po-Min,Tzeng Cheng-Hwai,Chan Yu-Jiun,Yang Muh-Hwa,Huang Yi-Hsiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference32 articles.

1. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab;Dervite;N Engl J Med,2001

2. Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report;Ng;Ann Hematol,2001

3. Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab;Hamaki;Am J Hematol,2001

4. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge;Skrabs;Leukemia,2002

5. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy;Westhoff;Blood,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Surface Antigen Reverse Seroconversion after Hematopoietic Stem Cell Transplantation According to Baseline Serological Markers and Vaccination Status: A Single-Center Database Analysis;2024-05-28

2. Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation;Biological and Pharmaceutical Bulletin;2024-05-10

3. Impact of hepatitis B surface and core antibody levels on hepatitis B virus reactivation;2023-10-23

4. Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses;International Journal of Molecular Sciences;2022-01-28

5. Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-02-27